532 related articles for article (PubMed ID: 31154474)
21. The potential therapeutic benefit of resveratrol on Th17/Treg imbalance in immune thrombocytopenic purpura.
Guo NH; Fu X; Zi FM; Song Y; Wang S; Cheng J
Int Immunopharmacol; 2019 Aug; 73():181-192. PubMed ID: 31102993
[TBL] [Abstract][Full Text] [Related]
22. Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome.
Ling Y; Cao X; Yu Z; Ruan C
Eur J Haematol; 2007 Oct; 79(4):310-6. PubMed ID: 17692100
[TBL] [Abstract][Full Text] [Related]
23. Adenosine Generated by Regulatory T Cells Induces CD8
Shi L; Feng M; Du S; Wei X; Song H; Yixin X; Song J; Wenxian G
Biomed Res Int; 2019; 2019():4093214. PubMed ID: 31930120
[TBL] [Abstract][Full Text] [Related]
24. Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura.
Liu B; Zhao H; Poon MC; Han Z; Gu D; Xu M; Jia H; Yang R; Han ZC
Eur J Haematol; 2007 Feb; 78(2):139-43. PubMed ID: 17328716
[TBL] [Abstract][Full Text] [Related]
25. Abnormality of regulatory T-cells in remission and non-remission idiopathic thrombocytopaenic purpura patients.
Teke HÜ; Gündüz E; Akay OM; Gülbas Z
Platelets; 2013; 24(8):625-31. PubMed ID: 23215839
[TBL] [Abstract][Full Text] [Related]
26. CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions through a CD39, adenosine-dependent mechanism.
Ring S; Oliver SJ; Cronstein BN; Enk AH; Mahnke K
J Allergy Clin Immunol; 2009 Jun; 123(6):1287-96.e2. PubMed ID: 19427686
[TBL] [Abstract][Full Text] [Related]
27. Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis.
Grant CR; Liberal R; Holder BS; Cardone J; Ma Y; Robson SC; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2014 Mar; 59(3):1007-15. PubMed ID: 23787765
[TBL] [Abstract][Full Text] [Related]
28. Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression.
Mandapathil M; Lang S; Gorelik E; Whiteside TL
J Immunol Methods; 2009 Jul; 346(1-2):55-63. PubMed ID: 19450601
[TBL] [Abstract][Full Text] [Related]
29. [Effect and mechanism of low-dose chidamide on the treatment of primary immune thrombocytopenia].
Zhao HY; Li DQ; Wang J; Hou Y; Sun L; Peng J; Hou M
Zhonghua Xue Ye Xue Za Zhi; 2020 Apr; 41(4):292-296. PubMed ID: 32447932
[No Abstract] [Full Text] [Related]
30. Long non-coding RNA MEG3 inhibits microRNA-125a-5p expression and induces immune imbalance of Treg/Th17 in immune thrombocytopenic purpura.
Li JQ; Hu SY; Wang ZY; Lin J; Jian S; Dong YC; Wu XF; Dai-Lan ; Cao LJ
Biomed Pharmacother; 2016 Oct; 83():905-911. PubMed ID: 27522004
[TBL] [Abstract][Full Text] [Related]
31. Functional role of CD4+CD25+ regulatory T cells and transforming growth factor-beta1 in childhood immune thrombocytopenic purpura.
Fahim NM; Monir E
Egypt J Immunol; 2006; 13(1):173-87. PubMed ID: 17974160
[TBL] [Abstract][Full Text] [Related]
32. Regulatory T cells regulate the distribution of natural killer T cells through CD39 signal transduction in asthma.
Lu Y; Li Y; Zhou W; Ding B; Yu Q
Hum Cell; 2019 Apr; 32(2):141-149. PubMed ID: 30539423
[TBL] [Abstract][Full Text] [Related]
33. Regulation of innate immunity by the nucleotide pathway in children with idiopathic nephrotic syndrome.
Bertelli R; Bodria M; Nobile M; Alloisio S; Barbieri R; Montobbio G; Patrone P; Ghiggeri GM
Clin Exp Immunol; 2011 Oct; 166(1):55-63. PubMed ID: 21762125
[TBL] [Abstract][Full Text] [Related]
34. Aberrant expression of microRNA in CD4
Hua M; Li J; Wang C; Shao L; Hou M; Peng J; Feng Q
Thromb Res; 2019 May; 177():70-78. PubMed ID: 30856381
[TBL] [Abstract][Full Text] [Related]
35. [Alterations of CD4+ CD25+ regulatory T cells in patients with idiopathic thrombocytopenic purpura].
Ling Y; Cao XS; Yu ZQ; Luo GH; Bai X; Su J; Dai L; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2007 Mar; 28(3):184-8. PubMed ID: 17649712
[TBL] [Abstract][Full Text] [Related]
36. CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis.
Gupta V; Katiyar S; Singh A; Misra R; Aggarwal A
Int J Rheum Dis; 2018 Aug; 21(8):1548-1556. PubMed ID: 30146748
[TBL] [Abstract][Full Text] [Related]
37. Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer.
Mandapathil M; Szczepanski MJ; Szajnik M; Ren J; Lenzner DE; Jackson EK; Gorelik E; Lang S; Johnson JT; Whiteside TL
Clin Cancer Res; 2009 Oct; 15(20):6348-57. PubMed ID: 19825957
[TBL] [Abstract][Full Text] [Related]
38. Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade.
Yang R; Elsaadi S; Misund K; Abdollahi P; Vandsemb EN; Moen SH; Kusnierczyk A; Slupphaug G; Standal T; Waage A; Slørdahl TS; Rø TB; Rustad E; Sundan A; Hay C; Cooper Z; Schuller AG; Woessner R; Borodovsky A; Menu E; Børset M; Sponaas AM
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32409420
[TBL] [Abstract][Full Text] [Related]
39. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.
Borsellino G; Kleinewietfeld M; Di Mitri D; Sternjak A; Diamantini A; Giometto R; Höpner S; Centonze D; Bernardi G; Dell'Acqua ML; Rossini PM; Battistini L; Rötzschke O; Falk K
Blood; 2007 Aug; 110(4):1225-32. PubMed ID: 17449799
[TBL] [Abstract][Full Text] [Related]
40. Human antigen-specific CD4⁺ CD25⁺ CD134⁺ CD39⁺ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses.
Seddiki N; Cook L; Hsu DC; Phetsouphanh C; Brown K; Xu Y; Kerr SJ; Cooper DA; Munier CM; Pett S; Ananworanich J; Zaunders J; Kelleher AD
Eur J Immunol; 2014 Jun; 44(6):1644-61. PubMed ID: 24752698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
